Walleye Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,000
| Closed | -$1.06M | – | 4837 |
|
|
2025
Q1 | $1.06M | Buy |
+8,000
| New | +$997K | ﹤0.01% | 2026 |
|
|
2024
Q3 | – | Sell |
-1,339
| Closed | -$91.7K | – | 4687 |
|
|
2024
Q2 | $91.7K | Sell |
1,339
-1,354
| -50% | -$93.9K | ﹤0.01% | 3401 |
|
|
2024
Q1 | $186K | Sell |
2,693
-568
| -17% | -$39K | ﹤0.01% | 3467 |
|
|
2023
Q4 | $234K | Sell |
3,261
-7,297
| -69% | -$420K | ﹤0.01% | 3679 |
|
|
2023
Q3 | $550K | Buy |
+10,558
| New | +$615K | ﹤0.01% | 2884 |
|
|
2023
Q2 | – | Sell |
-27,318
| Closed | -$1.48M | – | 5300 |
|
|
2023
Q1 | $1.48M | Buy |
27,318
+17,362
| +174% | +$839K | ﹤0.01% | 1905 |
|
|
2022
Q4 | $527K | Sell |
9,956
-25,978
| -72% | -$1.3M | ﹤0.01% | 2766 |
|
|
2022
Q3 | $1.67M | Buy |
35,934
+24,695
| +220% | +$1.29M | 0.01% | 1837 |
|
|
2022
Q2 | $642K | Buy |
11,239
+9,884
| +729% | +$560K | ﹤0.01% | 2659 |
|
|
2022
Q1 | $83K | Buy |
+1,355
| New | +$70.4K | ﹤0.01% | 4331 |
|
|
2021
Q1 | – | Sell |
-10,258
| Closed | -$356K | – | 5406 |
|
|
2020
Q4 | $326K | Buy |
10,258
+7,120
| +227% | +$187K | ﹤0.01% | 3059 |
|
|
2020
Q3 | $81K | Buy |
+3,138
| New | +$71.6K | ﹤0.01% | 3476 |
|
|
2020
Q2 | – | Sell |
-6,755
| Closed | -$104K | – | 4687 |
|
|
2020
Q1 | $104K | Sell |
6,755
-44,005
| -87% | -$956K | ﹤0.01% | 3087 |
|
|
2019
Q4 | $1.74M | Buy |
+50,760
| New | +$609K | 0.01% | 1326 |
|
|
2019
Q3 | – | Sell |
-42,426
| Closed | -$407K | – | 4507 |
|
|
2019
Q2 | $551K | Buy |
42,426
+8,398
| +25% | +$108K | ﹤0.01% | 2113 |
|
|
2019
Q1 | $414K | Buy |
34,028
+22,617
| +198% | +$289K | ﹤0.01% | 2427 |
|
|
2018
Q4 | $130K | Buy |
+11,411
| New | +$184K | ﹤0.01% | 3735 |
|
|
2017
Q3 | – | Sell |
-200
| Closed | -$2K | – | 4680 |
|
|
2017
Q2 | $2K | Buy |
+200
| New | +$2.32K | ﹤0.01% | 4415 |
|
Other funds holding ITCI
Walleye Trading's ITCI Position: Q2 2025 in Review
Walleye Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 8,000 shares — an estimated $1.06M sold.
Walleye Trading first reported a position in ITCI in Q2 2017 and held it in 18 quarters. The position peaked at $1.74M in Q4 2019. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Walleye Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 8,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.06M.
- Walleye Trading first reported a position in Intra-Cellular Therapies Inc. in Q2 2017 and held it in 18 quarters.
- Walleye Trading's Intra-Cellular Therapies Inc. position peaked at $1.74M in Q4 2019.
- 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.